A pair of SARS-CoV-2 nucleocapsid protein monoclonal antibodies shows high specificity and sensitivity for diagnosis

被引：0

作者：

AnKai Zhu ^{[1
]}

SaSa Li ^{[1
]}

ShuPei Yu ^{[1
]}

ZhaoYong Zhang ^{[2
]}

Huan Li ^{[1
]}

JingFeng Li ^{[1
]}

ShanShan Gao ^{[1
]}

Heng Chen ^{[1
]}

Jincun Zhao ^{[2
]}

Run Shi ^{[1
]}

Mingjian Lu ^{[3
]}

Chaoyang Li ^{[1
]}

机构：

[1] Affiliated Cancer Hospital and Institute of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Key Laboratory for Cell Homeostasis and Cancer Research of Guangdong High Education Institute

[2] State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University

[3] Department of Interventional Radiology, Affiliated Cancer Hospital and Institute of Guangzhou Medical

来源：

Virologica Sinica | 2022年 / 37卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R373 [人体病毒学（致病病毒）];

学科分类号：

摘要：

<正>Dear Editor,Severe Acute Respiratory Syndrome Coronavirus Type 2(SARS-CoV-2) is the pathogen of the coronavirus disease 2019(COVID-19), which has spread worldwide.SARS-CoV-2 is an enveloped virus belongs to the family of β-coronavirus(Xu et al., 2020). Its genome is a linear single-stranded positive-sense RNA about 30,000 nucleotides packed inside a virion with a diameter of 100 nm and a volume of about 106nm3(Bar-On et al., 2020).

引用

页码：942 / 945

页数：4

共 50 条

[21] Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests
Yamaoka, Yutaro
Miyakawa, Kei
Jeremiah, Sundararaj Stanleyraj
Funabashi, Rikako
Okudela, Koji
Kikuchi, Sayaka
Katada, Junichi
Wada, Atsuhiko
Takei, Toshiki
Nishi, Mayuko
Shimizu, Kohei
Ozawa, Hiroki
Usuku, Shuzo
Kawakami, Chiharu
Tanaka, Nobuko
Morita, Takeshi
Hayashi, Hiroyuki
Mitsui, Hideaki
Suzuki, Keita
Aizawa, Daisuke
Yoshimura, Yukihiro
Miyazaki, Tomoyuki
Yamazaki, Etsuko
Suzuki, Tadaki
Kimura, Hirokazu
Shimizu, Hideaki
Okabe, Nobuhiko
Hasegawa, Hideki
Ryo, Akihide
CELL REPORTS MEDICINE, 2021, 2 (06)
[22] Monoclonal neutralizing antibodies against SARS-COV-2 S protein
Cheng, Lin-Dong
Li, Ping
Lin, Yan-Chen
Hu, Hui-Xiu
Zhang, Ying
Li, Hou-Feng
Huang, Jing
Tan, Li
Ma, Ning
Xia, Deng-Yun
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (02): : 681 - 689
[23] Microfluidic Magneto Immunosensor for Rapid, High Sensitivity Measurements of SARS-CoV-2 Nucleocapsid Protein in Serum
Li, Jiran
Lillehoj, Peter B.
ACS SENSORS, 2021, 6 (03): : 1270 - 1278
[24] Biochemical characterization of SARS-CoV-2 nucleocapsid protein
Zeng, Weihong
Liu, Guangfeng
Ma, Huan
Zhao, Dan
Yang, Yunru
Liu, Muziying
Mohammed, Ahmed
Zhao, Changcheng
Yang, Yun
Xie, Jiajia
Ding, Chengchao
Ma, Xiaoling
Weng, Jianping
Gao, Yong
He, Hongliang
Jin, Tengchuan
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 527 (03) : 618 - 623
[25] Molecular characterization of SARS-CoV-2 nucleocapsid protein
Huang, Yanping
Chen, Junkai
Chen, Siwei
Huang, Congcong
Li, Bei
Li, Jian
Jin, Zhixiong
Zhang, Qiwei
Pan, Pan
Du, Weixing
Liu, Long
Liu, Zhixin
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
[26] DNA Folding by the SARS-CoV-2 Nucleocapsid Protein
Choi, Youna N.
McMillan, Ryan B.
Carter, Ashley R.
BIOPHYSICAL JOURNAL, 2021, 120 (03) : 34A - 34A
[27] DNA folding by SARS-CoV-2 nucleocapsid protein
Xing, Jonathan
Choi, Youna J.
Carter, Ashley
BIOPHYSICAL JOURNAL, 2024, 123 (03) : 227A - 227A
[28] Characterization of SARS-CoV-2 nucleocapsid protein oligomers
Farci, Domenica
Graca, Andre T.
Hall, Michael
Haniewicz, Patrycja
Kereiche, Sami
Faull, Peter
Kirkpatrick, Joanna
Tramontano, Enzo
Schroder, Wolfgang P.
Piano, Dario
JOURNAL OF STRUCTURAL BIOLOGY, 2025, 217 (01)
[29] Production and characterization of monoclonal antibodies against the nucleocapsid protein of SARS-CoV
Fang, Ying
Pekosz, Andrew
Haynes, Lia
Nelson, Eric A.
Rowland, Raymond R. R.
NIDOVIRUSES: TOWARD CONTROL OF SARS AND OTHER NIDOVIRUS DISEASES, 2006, 581 : 153 - 156
[30] Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
Yamasoba, Daichi
Kosugi, Yusuke
Kimura, Izumi
Fujita, Shigeru
Uriu, Keiya
Ito, Jumpei
Sato, Kei
LANCET INFECTIOUS DISEASES, 2022, 22 (07): : 942 - 943

← 1 2 3 4 5 →